Gastric cancer (GC) is a common cause of cancer-related deaths in the world. In addition to the patient’s clinical history and clinical examination, nuclear medicine tools are required for diagnosis. [18F]FDG PET/CT has been commonly used for cancer patients for staging, restaging, evaluation of treatment response. This study aimed to review the current literature on the role of [18F]FDG PET/CT for GC management
Objectives Fluorodeoxyglucose (FDG) positron emission tomography–computed tomography (PET-CT) is typ...
Objective: F-18-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT)...
The escalating costs of conventional diagnostic technology in oncology have yet to obviate futile su...
Background: Gastric cancer is one of the most common and leading causes of cancer death worldwide, w...
Background: Gastric cancer is one of the most common and leading causes of cancer death worldwide, w...
Objective: The aim of this study is to explore the role of 18F-FDG PET/CT in the primary staging of ...
Aerobic glycolysis has been the most important hypothesis in cancer metabolism. It seems to be relat...
Background/Aims: The role of 18F-fluorodeoxyglucose (18F-FDG) PET-CT for early gastric cancer (EGC) ...
F-18-fluorodeoxyglucose (FDG) PET/CT has been widely used for staging, re-staging and for monitoring...
Gastric cancer (GC) is a common cause of cancer-related deaths in the world. In addition to the pati...
Copyright © 2013 Bogdan Małkowski et al. This is an open access article distributed under the Creati...
Background and objective: Gastric cancer remains a leading cause of malignancy-related mortality. Ma...
AbstractFluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT)...
Objective: CT and staging laparoscopy are routinely used to stage patients with gastric cancer, how...
Purpose: To review the impact of 18F FDG-PET-CT scans on the management of patients with germ cell t...
Objectives Fluorodeoxyglucose (FDG) positron emission tomography–computed tomography (PET-CT) is typ...
Objective: F-18-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT)...
The escalating costs of conventional diagnostic technology in oncology have yet to obviate futile su...
Background: Gastric cancer is one of the most common and leading causes of cancer death worldwide, w...
Background: Gastric cancer is one of the most common and leading causes of cancer death worldwide, w...
Objective: The aim of this study is to explore the role of 18F-FDG PET/CT in the primary staging of ...
Aerobic glycolysis has been the most important hypothesis in cancer metabolism. It seems to be relat...
Background/Aims: The role of 18F-fluorodeoxyglucose (18F-FDG) PET-CT for early gastric cancer (EGC) ...
F-18-fluorodeoxyglucose (FDG) PET/CT has been widely used for staging, re-staging and for monitoring...
Gastric cancer (GC) is a common cause of cancer-related deaths in the world. In addition to the pati...
Copyright © 2013 Bogdan Małkowski et al. This is an open access article distributed under the Creati...
Background and objective: Gastric cancer remains a leading cause of malignancy-related mortality. Ma...
AbstractFluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT)...
Objective: CT and staging laparoscopy are routinely used to stage patients with gastric cancer, how...
Purpose: To review the impact of 18F FDG-PET-CT scans on the management of patients with germ cell t...
Objectives Fluorodeoxyglucose (FDG) positron emission tomography–computed tomography (PET-CT) is typ...
Objective: F-18-fluorodeoxyglucose positron emission tomography/computed tomography (18F-FDG PET/CT)...
The escalating costs of conventional diagnostic technology in oncology have yet to obviate futile su...